Health Care Down as Traders Bet on Growth Areas -- Health-Care Roundup

By Dow Jones Business News, 
A A A


Drug makers and health insurers fell slightly as traders hedged their bets on the outlook for deal activity and drug developments. Johnson & Johnson and Bayer AG announced plans Friday to launch clinical trials of the anticoagulant Xarelto against three new diseases in an ambitious bid to widen the market for a drug poised to exceed $1 billion in sales this year.

-Rob Curran, rob.curran@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


  (END) Dow Jones Newswires
  08-29-141652ET
  Copyright (c) 2014 Dow Jones & Company, Inc.


This article appears in: News Headlines

Referenced Stocks: BAYN , BAYRY , JNJ

Dow Jones Business News


More from Dow Jones Business News:

Related Videos

Stocks

Referenced

80%

Most Active by Volume

64,159,633
  • $100.86 ▼ 0.76%
63,552,623
  • $16.71 ▼ 0.18%
60,140,251
  • $42.71 ▲ 0.38%
52,385,870
  • $17.51 ▲ 5.86%
50,329,585
  • $13.75 ▲ 29.84%
43,337,551
  • $16.16 ▼ 1.40%
40,126,911
  • $3.605 ▲ 0.56%
39,836,742
  • $3.81 ▼ 2.56%
As of 9/16/2014, 04:15 PM